MetasTx LLC

MetasTx LLC

制药业

Basking Ridge,New Jersey 216 位关注者

DRIVEN TO CREATE NOVEL THERAPEUTICS TO TREAT AND PREVENT METASTASIS OF CANCER

关于我们

MetasTx is creating treatments that prevent and treat prostate cancer metastasis without affecting the Androgen System. An estimated 608,570 Americans died from cancer in 2021. The five-year survival rate of metastatic cancers, those that travel from the primary site to a distant site (also known as Stage 4 or 5), is approximately 30%. This area of research is ripe for advances. Unfortunately, current drug discovery in metastatic cancer has not resulted in therapies with significant increases in patient survival, specificity in drug delivery, or mitigation of deleterious side effects. MetasTx successfully concluded studies revealing the integral role of PAK1 in the regulation of epithelial-to-mesenchymal transition (EMT), a process necessary for early cancer cells to switch to metastatic ones. The stability and efficacy of MTX-101 are significantly superior in inhibiting prostate tumor growth and metastasis in various mouse models of prostate cancer and demonstrate broad applicability across solid tumor cancers.

网站
https://metastx.com/
所属行业
制药业
规模
2-10 人
总部
Basking Ridge,New Jersey
类型
私人持股
创立
2021

地点

  • 主要

    162 Smoke Rise Rd

    US,New Jersey,Basking Ridge,07920

    获取路线

MetasTx LLC员工

动态

相似主页

查看职位

融资

MetasTx LLC 共 1 轮

上一轮

种子前

US$100,000.00

Crunchbase 上查看更多信息